Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Finland: Police Tell Kids To Rat On Parents For 'Offensive' Facebook Posts Criticizing Politicians
Pakistani Mom Invites Daughter to 'Wedding Reception,' Burns Her Alive For Picking Own Husband
DC: 'Full-Scale Panic' Setting In On Eve Of Trump Presidency
While U.S. Media Celebrates Feminization of Boys, China Moves to Prevent 'Masculinity Crisis'
Report: Roger Stone 'Poisoned by Polonium-210'
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.